Gouteux J P, Bansimba P, Noireau F, Frezil J L
Med Trop (Mars). 1987 Jan-Mar;47(1):61-3.
A survey carried out on 101 patients has shown that the treatment of human sleeping sickness, theoretically free, is relatively costly. The average total cost amount to 58,000 F C.F.A., ranging from free treatment up to much as 110,000 F C.F.A. This high cost in part explains the cases where treatment is refused, something which has frequently been observed in the Congo. It would therefore be desirable for patients, who are significant epidemiological reservoirs of T. b. gambiense, to receive economic aid.
对101名患者进行的一项调查显示,理论上免费的人类昏睡病治疗成本相对较高。平均总成本达58,000非洲法郎,从免费治疗到高达110,000非洲法郎不等。这种高成本部分解释了治疗被拒绝的情况,这在刚果经常可以观察到。因此,对于作为布氏冈比亚锥虫重要流行病学传染源的患者来说,获得经济援助是很有必要的。